发明名称 NMR-METHOD FOR DETERMINING THE RISK OF DEVELOPING TYPE 2 DIABETES
摘要 <p>Methods for assessing the risk of developing Type 2 diabetes and other related disorders include obtaining an NMR derived reference spectrum for a known glucose concentration sample and storing this information as a reference standard. A patient blood sample is collected and NMR derived patient spectrums for the blood sample are obtained. The two NMR data sets (the reference and the patient) are compared and a glucose concentration is determined for the patient sample. The glucose concentration can be evaluated with a blood sample undergoing lipoprotein cholesterol evaluation. The NMR based test can be used to concurrently provide a glucose concentration and lipoprotein constituent values based on a single testing event. The disclosure also includes a multi-purpose test, i.e., a test which concurrently provides lipoprotein screening and coronary heart disease risk evaluation along with a diabetes screening and risk assessment for developing Type 2 diabetes. A method for assessing diabetes includes identifying the presence of diabetic dyslipidemia based on the values of predetermined NMR measured lipoprotein constituents.</p>
申请公布号 EP1171778(B1) 申请公布日期 2006.03.01
申请号 EP20000926111 申请日期 2000.04.19
申请人 LIPOSCIENCE, INC.;NORTH CAROLINA STATE UNIVERSITY 发明人 OTVOS, JAMES, D.;BENNETT, DENNIS, W.
分类号 G01R33/46;G01N24/08;G01N33/483;G01N33/53;G01N33/66;G01N33/68;G01N33/74;G01R33/465 主分类号 G01R33/46
代理机构 代理人
主权项
地址